Brevan Howard Capital Management’s Evolv Technologies EVLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$178K Sell
29,352
-113,159
-79% -$662K ﹤0.01% 1929
2025
Q4
$1.02M Buy
142,511
+33,922
+31% +$241K 0.01% 756
2025
Q3
$820K Sell
108,589
-22,002
-17% -$161K ﹤0.01% 997
2025
Q2
$815K Buy
130,591
+102,891
+371% +$476K ﹤0.01% 1153
2025
Q1
$86.4K Sell
27,700
-49,174
-64% -$173K ﹤0.01% 1061
2024
Q4
$304K Buy
+76,874
New +$270K ﹤0.01% 770

Other funds holding EVLV

Brevan Howard Capital Management's EVLV Position: Q1 2026 in Review

Brevan Howard Capital Management reduced its Evolv Technologies (EVLV) stake by 79% in Q1 2026, selling an estimated $662K and leaving 29,352 shares worth $178K. The position accounts for ﹤0.01% of the portfolio, ranked #1929.

Brevan Howard Capital Management first reported a position in EVLV in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.02M in Q4 2025. 260 funds tracked by Wall St. Rank hold EVLV as of Q1 2026.

  • Brevan Howard Capital Management held 29,352 shares of Evolv Technologies worth $178K as of Q1 2026.
  • Brevan Howard Capital Management sold 113,159 Evolv Technologies shares in Q1 2026, an estimated $662K.
  • Evolv Technologies made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #1929 holding.
  • Brevan Howard Capital Management first reported a position in Evolv Technologies in Q4 2024 and has held it in 6 quarters since.
  • Brevan Howard Capital Management's Evolv Technologies position peaked at $1.02M in Q4 2025.
  • 260 funds tracked by Wall St. Rank held Evolv Technologies as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.